Gene · 780
NIH grants1,553
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,553
Download this page as JSON| Grant | Title | DDR1 papers | Newest fiscal year |
|---|---|---|---|
| P50CA196530 | Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer | 1 | 2025 |
| P50CA236733 | Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer | 1 | 2025 |
| P50HD027802 | Differential Diagnosis in Learning Disabilities | 1 | 2025 |
| P51OD011092 | Support for National Primate Research Center | 1 | 2025 |
| R01AG076448 | TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease | 1 | 2025 |
| R01AI024717 | Genetic Linkage in Lupus | 1 | 2025 |
| R01AI136979 | Contribution of altered cell envelope metabolism to resistance to cell envelope-targeting antimicrobials in MRSA | 1 | 2025 |
| R01AI164424 | Nonreceptor tyrosine kinases in Systemic Lupus Erythematosus | 1 | 2025 |
| R01AR043369 | MITF from control of pigmentation to melanoma risk | 1 | 2025 |
| R01AR045192 | REGULATORS OF EPIDERMAL GENE EXPRESSION | 1 | 2025 |
| R01AR076965 | Regulatory Variants in Human Skin Diseases | 1 | 2025 |
| R01CA163336 | Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing Data | 1 | 2025 |
| R01CA164273 | Overcoming Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors | 1 | 2025 |
| R01CA175397 | Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches | 1 | 2025 |
| R01CA178441 | Combinatorial epigenetic-based prevention of breast cancer | 1 | 2025 |
| R01CA193837 | Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence | 1 | 2025 |
| R01CA198887 | MULTIPLEXED PROTEIN BIOMARKER-BASED ASSAY FOR THE DETECTION OF BLADDER CANCER | 1 | 2025 |
| R01CA200653 | Interaction between the Epitranscriptome and Metabolism in L-2HG Driven Kidney Cancer | 1 | 2025 |
| R01CA207772 | Roles of Hsp47 in Breast Cancer Progression | 1 | 2025 |
| R01CA211066 | Intersection of autophagy and vesicle trafficking in Her2-positive breast cancer | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/grants?page=8